APOTHEEK PHARMAGO: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
APOTHEEK PHARMAGO
Largest movements
- Receivables within one year +€91,292
up €91,292 (+53.0%), from €172,142 to €263,434
of which Other amounts receivable: +€83,219
- Tangible fixed assets -€39,555
down €39,555 (-7.6%), from €518,680 to €479,124
of which Land and buildings: -€37,380
- Stocks and contracts +€16,006
up €16,006 (+6.9%), from €232,301 to €248,306
- Other debts +€56,038
up €56,038 (+38.0%), from €147,478 to €203,516
- Debts after one year -€32,563
down €32,563 (-9.1%), from €358,310 to €325,747
- Tax, wage and social debts +€20,416
up €20,416 (+44.7%), from €45,721 to €66,136
of which Taxes: +€19,617
- Trade debts +€19,058
up €19,058 (+11.7%), from €163,520 to €182,577
- Gross operating margin +€30,400
up €30,400 (+7.5%), from €405,967 to €436,367
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,131,889 | €1,195,722 | +€63,833 | +5.6% |
| Fixed assets | 21/28 | €521,180 | €486,624 | -€34,555 | -6.6% |
| Tangible fixed assets | 22/27 | €518,680 | €479,124 | -€39,555 | -7.6% |
| Land and buildings | 22 | €511,505 | €474,125 | -€37,380 | -7.3% |
| Plant, machinery and equipment | 23 | €2,933 | €1,856 | -€1,077 | -36.7% |
| Furniture and vehicles | 24 | €621 | €335 | -€285 | -46.0% |
| Other tangible fixed assets | 26 | €3,621 | €2,808 | -€813 | -22.5% |
| Financial fixed assets | 28 | €2,500 | €7,500 | +€5,000 | +200% |
| Current assets | 29/58 | €610,709 | €709,097 | +€98,388 | +16.1% |
| Stocks and contracts in progress | 3 | €232,301 | €248,306 | +€16,006 | +6.9% |
| Stocks | 30/36 | €232,301 | €248,306 | +€16,006 | +6.9% |
| Amounts receivable within one year | 40/41 | €172,142 | €263,434 | +€91,292 | +53.0% |
| Trade receivables | 40 | €158,108 | €166,181 | +€8,073 | +5.1% |
| Other amounts receivable | 41 | €14,034 | €97,253 | +€83,219 | +593% |
| Cash at bank and in hand | 54/58 | €198,552 | €186,821 | -€11,731 | -5.9% |
| Deferred charges and accrued income | 490/1 | €7,714 | €10,535 | +€2,822 | +36.6% |
| Total equity and liabilities | 10/49 | €1,131,889 | €1,195,722 | +€63,833 | +5.6% |
| Equity | 10/15 | €365,530 | €365,868 | +€338 | +0.1% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €346,930 | €347,268 | +€338 | +0.1% |
| Tax-exempt reserves | 132 | €10,750 | €10,750 | = | 0.0% |
| Distributable reserves | 133 | €336,180 | €336,518 | +€338 | +0.1% |
| Profit (loss) carried forward | 14 | €0 | €0 | = | |
| Amounts payable | 17/49 | €766,358 | €829,853 | +€63,495 | +8.3% |
| Amounts payable after more than one year | 17 | €358,310 | €325,747 | -€32,563 | -9.1% |
| Financial debts | 170/4 | €358,310 | €325,747 | -€32,563 | -9.1% |
| Amounts payable within one year | 42/48 | €392,848 | €485,183 | +€92,335 | +23.5% |
| Current portion of amounts payable after more than one year | 42 | €30,872 | €32,328 | +€1,456 | +4.7% |
| Trade debts | 44 | €163,520 | €182,577 | +€19,058 | +11.7% |
| Suppliers | 440/4 | €163,520 | €182,577 | +€19,058 | +11.7% |
| Advances received on contracts in progress | 46 | €5,258 | €625 | -€4,633 | -88.1% |
| Taxes, remuneration and social security | 45 | €45,721 | €66,136 | +€20,416 | +44.7% |
| Taxes | 450/3 | €4,561 | €24,178 | +€19,617 | +430% |
| Remuneration and social security | 454/9 | €41,160 | €41,959 | +€799 | +1.9% |
| Other amounts payable | 47/48 | €147,478 | €203,516 | +€56,038 | +38.0% |
| Accrued charges and deferred income | 492/3 | €15,200 | €18,923 | +€3,723 | +24.5% |
| Remuneration, social security and pensions | 62 | €316,317 | €316,459 | +€142 | 0.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €39,087 | €39,555 | +€468 | +1.2% |
| Other operating charges | 640/8 | €5,750 | €5,505 | -€246 | -4.3% |
| Gross operating margin | 9900 | €405,967 | €436,367 | +€30,400 | +7.5% |
| Operating profit (loss) | 9901 | €44,813 | €74,848 | +€30,035 | +67.0% |
| Financial income | 75/76B | €3,493 | €5,228 | +€1,735 | +49.7% |
| Recurring financial income | 75 | €3,493 | €5,228 | +€1,735 | +49.7% |
| Financial charges | 65/66B | €27,122 | €27,171 | +€50 | +0.2% |
| Recurring financial charges | 65 | €27,122 | €27,171 | +€50 | +0.2% |
| Profit (loss) for the period before taxes | 9903 | €21,185 | €52,905 | +€31,720 | +150% |
| Income taxes | 67/77 | €6,752 | €7,412 | +€660 | +9.8% |
| Profit (loss) for the period | 9904 | €14,433 | €45,493 | +€31,060 | +215% |
| Profit (loss) for the period to be appropriated | 9905 | €14,433 | €45,493 | +€31,060 | +215% |
Source: filed annual accounts (NBB), financial years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 19 October 2026 via checked.be.